References
1. Мамедов, М. Н. Метаболический синдром: пути реализации атеротромбогенного потенциала / М. Н. Мамедов, В. А. Метельская, Н. В. Перова // Кардиология. - 2000. - № 2. - С. 83-89.
2. Allison, M. A. Body morphology differentially predicts coronary calcium / M. A. Allison, C. M. Wright еt al. // J. Obes. Relat. Metab. Disord. - 2004. - Vol. 2. - P. 396-401.
3. Anand, S. S. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population / S. S. Anand, F. Razak, Q. Yi еt al. // J. Arterioscler. Thromb. Vasc. Biol. - 2004. - Vol. 24, № 8. - Р. 1509-1515.
4. Azizi, F. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study / F. Azizi, P. Salehi, A. Etemadi еt al. // J. Diabetes Res. Clin. Pract. - 2003. - Vol. 61, № 1. - Р. 29-37.
5. Banerji, M. A. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men / M. A. Banerji, N. Faridi, R. Atluri еt al. // J. Clin. Endocrinol. Metab. - 1999. - Vol. - 84, № 1. - Р. 137-144.
6. Boden, G. Lipids and glucose in type 2 diabetes: what is the cause and effect / G. Boden, M. Laakso еt al. // J. Diabetes Care. - 2004. - Vol. 27, № 9. - Р. 2253-2599.
7. Byrne, C. D. The Metabolic Syndrome And Primary Care / C. D. Byrne, S. Н. Wild еt al. - Jon Wiley & Sons Ltd, 2007. - P. 135.
8. Chandran, M. Adiponectin: more than just another fat cell hormone / M. Chandran, S. Phillips, T. Ciaraldi et al. // J. Diabetes Care. - 2003. - Vol. 26, № 8. - Р. 2442-2450.
9. Chen, Y. H. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms / Y. H. Chen, S. Lin, F. Lin et al. // J. Diabetes. - 2007. - Vol. 56. - P. 1559-1568.
10. Dнez, J. J. The role of the novel adipocyte-derived hormone adiponectin in human disease / J. J.Dнez, P. Iglesias et al. // J. Endocrinol. - 2003. - Vol. 148, № 3. - Р. 293-300.
11. Eckel, R. H. The metabolic syndrome / R. H. Eckel, S. Grundy, P. Zimmet et al. // J. Lancet. - 2005. - Vol. 365, № 22. - Р. 1415-1428.
12. Ford, E. S. Increasing prevalence of the metabolic syndrome among u. s. Adults / E. S. Ford, W. Giles, A. Mokdad et al. // J. Diabetes Care. - 2004. - Vol. 27, № 10. - Р. 2444-2449.
13. Ford, E. S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study / E. S. Ford et al. // J. Atherosclerosis. - 2004. - Vol. 173, № 2. - Р. 309-314.
14. Freeman, D. J. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study/ D. J. Freeman, J. Norrie, M. Caslake et al. // J. Diabetes. - 2002. - Vol. 51, № 5. - Р. 1596-1600.
15. Fumeron, F. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study / F. Fumeron, R. Aubert, A. Siddiq et al. // J. Diabetes. - 2004. - Vol. 53, № 4. - Р. 1150-1157.
16. Goldstein, B. J. Adiponectin: A novel adipokine linking adipocytes and vascular function / B. J. Goldstein, R. Scalia et al. // J. Clin. Endocrinol. Metab. - 2004. - Vol. 89, № 6. - Р. 2563-2568
17. Grundy, S. M. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement / S. M. Grundy, L. Cleeman, S. Daniels et al. // J. Circulation. - 2005. - Vol. 112, № 17. - Р. 2735-2752.
18. Guzder, R. N. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes / R. Guzder, W. Gatling, M. Mullee et al. // J. Diabetologia. - 2006. - Vol. 49, № 1. - Р. 49-55.
19. Han, T. S. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study / T. S. Han, N. Sattar, K. Williams et al. // Diabetes Care. - 2002. - Vol. 25, № 11. - Р. 2016-2021.
20. Hunt, K. J. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study / K. J. Hunt, R. Resendez, K. Williams et al. // J. Circulation. - 2004. - Vol. 110, № 10. - P. 1251-1257.
21. Kahan, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes / S. E. Kahan et al. // J. Diabetologia. - 2003. - № 46. - Р. 3-19.
22. Kenchaiah, S. Obesity and the risk of heart failure / S. Kenchaiah, J. Evans, D. Levy et al. // J. Med. - 2002. - Vol. 347. - Р. 305-313.
23. Knowler, W. C. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin / W. C. Knowler, E. Barrett-Connor, S. Fowler et al. // J. Med. - 2002. - Vol. 346, № 6. - Р. 393-403.
24. Laaksonen, D. E. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men / D. E. Laaksonen, L. Niskanen, K. Nyyssцnen et al. // J. Diabetologia. - 2004. - Vol. 47, № 8. - P. 1403-1410.
25. Lakka, H. M. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men / H. M. Lakka, D. E. Laaksonen, T. Lakka et al. // JAMA. - 2002. - Vol. 288, № 21. - Р. 2709-2716.
26. Li, Q. NF-kappaB regulation in the immune system / Q. Li, I. Verma et al. // J. Nat. Rev. Immunol. - 2002. - Vol. 2, № 10. - Р. 725-734.
27. Malik, S. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults / S. Malik, N. Wong, S. Franklin et al. // J. Circulation. - 2004. - Vol. 110, № 10. - Р. 1245-1250.
28. McNeill, A. M. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study / A. M. McNeill, W. Rosamond, C. Girman et al. // J. Diabetes Care. - 2005. - Vol. 28, № 2. - Р. 385-390.
29. Meigs, J. B. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies / J. B. Meigs, P. Wilson, D. Nathan et al. // J. Diabetes. - 2003. - Vol. 52, № 8. - Р. 2160-2167.
30. Mittel, S. The Metabolic Syndrome in Clinical Practice / S. Mittel et al. - UK: Springer Science, 2008. - Р. 259.
31. Mouquet, F. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1 / F. Mouquet, F. Cuilleret, S. Susen et al. // Eur. Heart J. - 2009. - Vol. 30, № 7. - Р. 840-849.
32. Nakanishi, N. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men / N. Nakanishi, T. Takatorige, H. Fukuda et al. // J. Diabetes Res. Clin. Pract. - 2004. - Vol. 64, № 1. - Р. 59-70.
33. Rutter, M. K. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study / M. K. Rutter, J. B. Meigs, L. Sullivan et al. // J. Circulation. - 2004. - Vol. 110, № 4. - Р. 380-385
34. Sacks, F. M. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors / F. M. Sacks, A. Tonkin, T. Craven et al. // J. Circulation. - 2002. - Vol. 105, № 12. - Р. 1424-1428.
35. Simon, G. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual / G. Simon, M. St-Onge, I. Janssen et al. // J. Diabetes Care. - 2004. - Vol. 27, № 9. - Р. 2222-2228.
36. Stanner, S. Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors British Nutrition Foundation / S. Stanner. - London: Blackwell, 2005.
37. Tan, K. C. C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance / K. C. Tan, N. Wat, S. Tam et al. // J. Diabetes Care. - 2003. - Vol. 26, № 8. - Р. 2323-2328.
38. Yamauchi, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects / T. Yamauchi, J. Kamon, Y. Ito et al. // J. Nature. - 2003. - Vol. 423, № 6. - Р. 762-769.